Predictors of Response to Direct Acting Anti-Viral Therapy in Patients With Decompensated Hepatitis C Cirrhosis

被引：0
|
作者：
Debnath, Prasanta, II
Chandnani, Sanjay
Rathi, Pravin
Nair, Sujit
Udgirkar, Suhas
机构：
[1] Topiwalla Natl Med Coll, Mumbai, Maharashtra, India
[2] BYL Nair Charitable Hosp, Mumbai, Maharashtra, India
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
10.14309/01.ajg.0000593444.12705.94
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
977
引用
收藏
页码：S568 / S568
页数：1
相关论文
共 50 条
  • [21] Chronic hepatitis C - Genotypes and response to anti-viral therapy among Saudi patients
    Al-Traif, I
    Handoo, FA
    Al-Jumah, A
    Al-Nasser, M
    SAUDI MEDICAL JOURNAL, 2004, 25 (12) : 1935 - 1938
  • [22] Influence factors and predictors in anti-viral therapy for chronic hepatitis C.
    金生
    周卫平
    张大志
    中华肝脏病杂志, 2004, (02) : 69 - 70
  • [23] Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
    Cheung, Michelle C. M.
    Walker, Alex J.
    Hudson, Benjamin E.
    Verma, Suman
    McLauchlan, John
    Mutimer, David J.
    Brown, Ashley
    Gelson, William T. H.
    MacDonald, Douglas C.
    Agarwal, Kosh
    Foster, Graham R.
    Irving, William L.
    JOURNAL OF HEPATOLOGY, 2016, 65 (04) : 741 - 747
  • [24] Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong
    Chow, Victor Yung Sin
    Cheung, Veronica Wing I.
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1195 - S1195
  • [25] Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong
    Victor Yung Sin Chow
    Wing I Cheung
    BMC Gastroenterology, 24
  • [26] Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong
    Chow, Victor Yung Sin
    Cheung, Wing, I
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [27] Direct acting anti-viral medications for hepatitis C: Clinical trials in patients with advanced chronic kidney disease
    Bruchfeld, Annette
    Lindahl, Karin
    SEMINARS IN DIALYSIS, 2019, 32 (02) : 135 - 140
  • [28] Direct Acting Anti-Viral Drugs Improve Health-Related Quality of Life in Patients' with Hepatitis C
    Morad, Wesam
    Othman, Warda
    Elshimi, Esam
    Shebl, Nashwa
    AMERICAN JOURNAL OF INFECTIOUS DISEASES, 2020, 16 (02) : 44 - 54
  • [29] DIRECT ACTING ANTI-VIRAL (DAA) THERAPIES ARE SAFE AND EFFECTIVE IN OCTOGENARIAN PATIENTS WITH CHRONIC HEPATITIS C INFECTION
    Bernstein, David
    Lee, Susan
    Lee, Tai Ping
    Tiev, Maly
    GASTROENTEROLOGY, 2018, 154 (06) : S1198 - S1198
  • [30] Hepatocellular carcinoma development in hepatitis C virus patients who achieved sustained viral response by interferon therapy and direct anti-viral agents therapy
    Nagaoki, Yuko
    Aikata, Hiroshi
    Kobayashi, Tomoki
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Kawakami, Yoshiiku
    Chayama, Kazuaki
    HEPATOLOGY, 2016, 64 : 424A - 424A
12345